These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 9221657

  • 1. [The dynamics of the formation of IgG subclasses in Balb/c and CBA mice infected with the LCM, Lassa and Mopeia viruses and their role in diagnosis].
    Zaĭtseva VN, Bystrova SI, Shkolina TV, Vladyko AS.
    Zh Mikrobiol Epidemiol Immunobiol; 1997; (1):47-51. PubMed ID: 9221657
    [Abstract] [Full Text] [Related]

  • 2. Antibodies to Lassa and Lassa-like viruses in man and mammals in the Central African Republic.
    Georges AJ, Gonzalez JP, Abdul-Wahid S, Saluzzo JF, Meunier DM, McCormick JB.
    Trans R Soc Trop Med Hyg; 1985; 79(1):78-9. PubMed ID: 2986324
    [Abstract] [Full Text] [Related]

  • 3. Monoclonal antibodies to lymphocytic choriomeningitis virus react with pathogenic arenaviruses.
    Buchmeier MJ, Lewicki HA, Tomori O, Johnson KM.
    Nature; 1980 Dec 04; 288(5790):486-7. PubMed ID: 6160402
    [Abstract] [Full Text] [Related]

  • 4. A Vaccine Platform against Arenaviruses Based on a Recombinant Hyperattenuated Mopeia Virus Expressing Heterologous Glycoproteins.
    Carnec X, Mateo M, Page A, Reynard S, Hortion J, Picard C, Yekwa E, Barrot L, Barron S, Vallve A, Raoul H, Carbonnelle C, Ferron F, Baize S.
    J Virol; 2018 Jun 15; 92(12):. PubMed ID: 29593043
    [Abstract] [Full Text] [Related]

  • 5. Detection of Lassa virus antigens and Lassa virus-specific immunoglobulins G and M by enzyme-linked immunosorbent assay.
    Niklasson BS, Jahrling PB, Peters CJ.
    J Clin Microbiol; 1984 Aug 15; 20(2):239-44. PubMed ID: 6386846
    [Abstract] [Full Text] [Related]

  • 6. RT-PCR assay for detection of Lassa virus and related Old World arenaviruses targeting the L gene.
    Vieth S, Drosten C, Lenz O, Vincent M, Omilabu S, Hass M, Becker-Ziaja B, ter Meulen J, Nichol ST, Schmitz H, Günther S.
    Trans R Soc Trop Med Hyg; 2007 Dec 15; 101(12):1253-64. PubMed ID: 17905372
    [Abstract] [Full Text] [Related]

  • 7. [Dynamics of antigen and antibody accumulation in adult mice, infected with Lassa virus].
    Vladyko AS, Surikova LE, Kramarenko LP, Bystrova SI, Torop AV.
    Vopr Virusol; 1989 Dec 15; 34(1):100-3. PubMed ID: 2658319
    [No Abstract] [Full Text] [Related]

  • 8. [Arenaviruses].
    Gaĭdamovich SIa, Kocherovskaia MIu.
    Vopr Virusol; 1978 Dec 15; (1):5-15. PubMed ID: 206025
    [No Abstract] [Full Text] [Related]

  • 9. Evaluating the immunogenicity and protective efficacy of a DNA vaccine encoding Lassa virus nucleoprotein.
    Rodriguez-Carreno MP, Nelson MS, Botten J, Smith-Nixon K, Buchmeier MJ, Whitton JL.
    Virology; 2005 Apr 25; 335(1):87-98. PubMed ID: 15823608
    [Abstract] [Full Text] [Related]

  • 10. Epitope mapping of the Lassa virus nucleoprotein using monoclonal anti-nucleocapsid antibodies.
    Hufert FT, Lüdke W, Schmitz H.
    Arch Virol; 1989 Apr 25; 106(3-4):201-12. PubMed ID: 2476109
    [Abstract] [Full Text] [Related]

  • 11. Development and evaluation of antibody-capture immunoassays for detection of Lassa virus nucleoprotein-specific immunoglobulin M and G.
    Gabriel M, Adomeh DI, Ehimuan J, Oyakhilome J, Omomoh EO, Ighodalo Y, Olokor T, Bonney K, Pahlmann M, Emmerich P, Lelke M, Brunotte L, Ölschläger S, Thomé-Bolduan C, Becker-Ziaja B, Busch C, Odia I, Ogbaini-Emovon E, Okokhere PO, Okogbenin SA, Akpede GO, Schmitz H, Asogun DA, Günther S.
    PLoS Negl Trop Dis; 2018 Mar 25; 12(3):e0006361. PubMed ID: 29596412
    [Abstract] [Full Text] [Related]

  • 12. Reverse ELISA for IgG and IgM antibodies to detect Lassa virus infections in Africa.
    Emmerich P, Thome-Bolduan C, Drosten C, Gunther S, Ban E, Sawinsky I, Schmitz H.
    J Clin Virol; 2006 Dec 25; 37(4):277-81. PubMed ID: 16996789
    [Abstract] [Full Text] [Related]

  • 13. [The localization and preliminary characteristics of antigenic sites (B epitopes) in the nucleocapsid protein of the Lassa virus].
    Vladyko AS, Bystrova SI, Malakhova IV, Kunitskaia LIa, Lemeshko NN, Kras'ko AG, Kozhich AT, Lukashevich IS.
    Vopr Virusol; 1993 Dec 25; 38(1):30-4. PubMed ID: 7521097
    [Abstract] [Full Text] [Related]

  • 14. Diagnosis and clinical virology of Lassa fever as evaluated by enzyme-linked immunosorbent assay, indirect fluorescent-antibody test, and virus isolation.
    Bausch DG, Rollin PE, Demby AH, Coulibaly M, Kanu J, Conteh AS, Wagoner KD, McMullan LK, Bowen MD, Peters CJ, Ksiazek TG.
    J Clin Microbiol; 2000 Jul 25; 38(7):2670-7. PubMed ID: 10878062
    [Abstract] [Full Text] [Related]

  • 15. Mucosal immunization with Salmonella typhimurium expressing Lassa virus nucleocapsid protein cross-protects mice from lethal challenge with lymphocytic choriomeningitis virus.
    Djavani M, Yin C, Lukashevich IS, Rodas J, Rai SK, Salvato MS.
    J Hum Virol; 2001 Jul 25; 4(2):103-8. PubMed ID: 11437313
    [Abstract] [Full Text] [Related]

  • 16. ELISA and indirect immunofluorescence in the diagnosis of LCM virus infections.
    Turković B, Ljubicić M.
    Acta Virol; 1992 Dec 25; 36(6):576-80. PubMed ID: 1363992
    [Abstract] [Full Text] [Related]

  • 17. Indirect solid-phase immunosorbent assay for detection of arenavirus antigens and antibodies.
    Ivanov AP, Rezapkin GV, Dzagurova TK, Tkachenko EA.
    Acta Virol; 1984 May 25; 28(3):240-5. PubMed ID: 6148001
    [Abstract] [Full Text] [Related]

  • 18. Lassa Virus Vaccine Candidate ML29 Generates Truncated Viral RNAs Which Contribute to Interfering Activity and Attenuation.
    Johnson DM, Cubitt B, Pfeffer TL, de la Torre JC, Lukashevich IS.
    Viruses; 2021 Jan 30; 13(2):. PubMed ID: 33573250
    [Abstract] [Full Text] [Related]

  • 19. Antigenic relatedness between arenaviruses defined at the epitope level by monoclonal antibodies.
    Ruo SL, Mitchell SW, Kiley MP, Roumillat LF, Fisher-Hoch SP, McCormick JB.
    J Gen Virol; 1991 Mar 30; 72 ( Pt 3)():549-55. PubMed ID: 1706408
    [Abstract] [Full Text] [Related]

  • 20. A live attenuated vaccine for Lassa fever made by reassortment of Lassa and Mopeia viruses.
    Lukashevich IS, Patterson J, Carrion R, Moshkoff D, Ticer A, Zapata J, Brasky K, Geiger R, Hubbard GB, Bryant J, Salvato MS.
    J Virol; 2005 Nov 30; 79(22):13934-42. PubMed ID: 16254329
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.